The U.S. P2Y12 inhibitors market is estimated to be valued at US$215.7 Million In 2021 and is expected to exhibit a CAGR of 3.8% over the forecast period, according to a new report published by Coherent Market Insights. The market for P2Y12 inhibitors is driven by the increasing demand for antiplatelet drugs, which are used to prevent blood clotting in individuals with a history of cardiovascular diseases or recent heart surgeries. P2Y12 inhibitors are ... Read more
